Pharmacokinetics of Drug Distribution

Physicochemical Drivers of Distribution

Several molecular factors determine whether a drug will stay in the blood or penetrate deep into tissues.

Lipid-Water Partition Coefficient and Lipophilicity

The lipid-water partition coefficient measures the ratio of a drug's concentration in two immiscible phases (fatty/lipid vs. watery/aqueous). This is a direct measure of lipophilicity (fat-solubility) versus hydrophilicity (water-solubility). Generally, the more lipophilic a drug is, the more easily it can cross biological membranes to distribute into tissues.

$pK_a$ and Ionization

The $pK_a$ of a drug is the pH at which 50% of the drug exists in its ionized (charged) form and 50% exists in its un-ionized (uncharged) form.

• Un-ionized forms are typically lipophilic and can easily cross membranes.
• Ionized forms are typically hydrophilic and struggle to cross lipid bilayers.

At physiological pH, a lower $pK_a$ value generally correlates with higher lipophilicity.

Plasma Protein Binding

Once in the blood, many drugs bind to plasma proteins. This binding is usually reversible.

• Acidic drugs tend to bind to albumin.
• Basic drugs tend to bind to glycoproteins.

Crucially, only the unbound (free) fraction of the drug is pharmacologically active and capable of diffusing through cell membranes. Drugs that are highly protein-bound often stay in the body longer, resulting in a longer duration of action.

Physiological and Pathological Influences

Distribution is not uniform across all individuals; it is heavily influenced by biological variables.

Tissue Storage and Affinity

Some drugs have a high affinity for specific tissues and may accumulate there via active transport or binding to tissue components. For example, tetracycline can be sequestered in bone and teeth, which can lead to tooth discoloration. High tissue storage leads to a larger $V_d$ and a longer duration of action.

Body Composition

The ratio of fat to lean body mass significantly impacts distribution:

• Obese individuals may store much higher amounts of fat-soluble (lipophilic) drugs.
• Elderly individuals may also store more fat-soluble drugs because the proportion of body fat typically increases with age, even if they appear thin.

Pathological States

Diseases can alter the concentration of plasma proteins. If a disease reduces the amount of available albumin, the "free fraction" of a drug increases, which can drastically change the $V_d$ and potentially lead to toxicity.

Specialized Physiological Barriers

The body employs specialized barriers to protect sensitive areas from chemical fluctuations.

The Blood-Brain Barrier (BBB)

The BBB is a highly selective structure composed of capillary endothelial cells that are tightly joined together, lacking the "gaps" (paracellular spaces) found in other capillaries.

• It primarily allows lipophilic substances to pass.
• It contains specific enzymes that prevent the entry of certain molecules, such as active catecholamines.

The Placental Barrier

The placenta consists of lipoidal membranes that regulate the movement of substances between the mother and the fetus.

• Lipophilic drugs can pass through easily.
• Hydrophilic drugs are generally restricted.

While the placenta acts as a barrier to limit fetal exposure, it is also a site for drug metabolism. High concentrations of drugs taken over long periods may eventually bypass these protections.

---

Summary Table: Drug Properties and Distribution